Company intelligence / Profile preview

Cells Good

Xizhi District, New Taipei City, Taiwan

Ownership: Private
Development stage: Other

Overview

Cells Good Bio-Tech is a biotechnology company focused on the research, development, and clinical application of immune cell therapies, specifically Natural Killer (NK) cell expansion and storage technologies. Based in Taiwan, the company operates under the 'Special Regulations for Cell Therapy' (Special Act), allowing it to partner with medical institutions to provide autologous cell treatments for cancer patients. Their technology platform focuses on high-purity expansion of NK cells and Dendritic cells for precision medicine applications in oncology.

Therapeutic areas: Oncology
Modalities: Cell therapyNK cell therapyDendritic cell therapyCIK cell therapy
Industry: Biotech

Partnerships

Taipei Medical University HospitalSijhih Cathay General HospitalTaipei Municipal Wanfang Hospital

Beyond the preview

Go deeper on Cells Good.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cells Good.

Explore the full profile